Effects of Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta‐Analysis

BACKGROUND: The original non–vitamin K antagonist oral anticoagulant (NOAC) trials in nonvalvular atrial fibrillation (AF) enrolled patients with native valve pathologies. The object of this study was to quantify the benefit–risk profiles of NOACs versus warfarin in AF patients with native valvular...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Kuo‐Li, Singer, Daniel E., Ovbiagele, Bruce, Wu, Yi‐Ling, Ahmed, Mohamed A., Lee, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Systematic Review and Meta‐Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586302/
https://www.ncbi.nlm.nih.gov/pubmed/28720644
http://dx.doi.org/10.1161/JAHA.117.005835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586302/
https://www.ncbi.nlm.nih.gov/pubmed/28720644
http://dx.doi.org/10.1161/JAHA.117.005835

Ejemplares similares